SGRY Shareholder Notice: Surgery Partners $23.50 per Share Merger Under Investigation on Behalf of Shareholders

What happened

Surgery Partners said on October 26, 2026, that Bon Secours Mercy Health would take the company private for $23.50 per share. The notice says largest stockholder Bain Capital would roll its equity into the post-merger company, while other shareholders would be cashed out. BFA Law is investigating the deal.

Confirmed

Global impact / market context

The proposed cash-out price sets the stated payment for shareholders other than Bain Capital, while Bain’s equity rollover would leave it invested in the combined company. The investigation raises questions about how the deal treats different shareholder groups, which could influence whether investors seek more information or challenge the transaction.

Analyst inference

The notice describes a proposed take-private transaction, meaning Surgery Partners would no longer be publicly traded if the deal closes. It provides no completion date, financing details, or investor response, so the information supports assessing the stated terms rather than judging the likelihood or value of completion.

Analyst inference

What to watch

1. Watch for updates from Surgery Partners on whether the proposed $23.50-per-share transaction advances, since a change in terms could alter the cash payment expected by other shareholders. Analyst inference
2. Look for further information about Bain Capital’s equity rollover and the treatment of other shareholders; those details could clarify the difference between remaining invested and receiving cash. Analyst inference
3. BFA Law is inviting current shareholders to contact the firm about the investigation. Any disclosed legal challenge or company response could affect the transaction’s path or timing. Confirmed

Evidence

• Original source link unavailable